Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |